Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.41 AUD | +1.31% | -11.31% | -12.03% |
May. 10 | Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents | MT |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.03% | 288M | |
+18.71% | 44.35B | |
+19.44% | 15.08B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-9.70% | 6.75B | |
-8.87% | 5.73B | |
+12.55% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Transcript : Mayne Pharma Group Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 07